[CLINICAL RESEARCH WITH A COMPOUND HYPOTENSIVE PREPARATION (MEBUTAMATE + 1-4 DIHYDRAZINOPHTHALAZINE + DIHYDROCHLOROTHIAZIDE +   POTASSIUM)].
D000959:Antihypertensive Agents; D001161:Arteriosclerosis; D002219:Carbamates; D006801:Humans; D006830:Hydralazine; D006852:Hydrochlorothiazide; D006973:Hypertension; D006977:Hypertension, Renal; D007668:Kidney; D009393:Nephritis; D009400:Nephrosclerosis; D011188:Potassium
D000959:Antihypertensive Agents; D002219:Carbamates; D006852:Hydrochlorothiazide; D006830:Hydralazine; D011188:Potassium
ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPERTENSION, RENAL; MEBUTAMATE; NEPHRITIS; NEPHROSCLEROSIS; POTASSIUM
RICERCHE CLINICHE CON UN PREPARATO IPOTENSIVO COMPOSTO (MEBUTAMATO + 1-4 DIIDRAZINOFTALAZINA + DI-IDROCLOROTIAZIDE + POTASSIO)